Taken together, these results identify a β-cell population which remains amylin positive while losing insulin expression and demonstrate the ability of methylation-specific primers to detect an increase in amylin cfDNA at the time of disease presentation in the NOD model of T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.